Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a Reply. Please see:

Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al - March 01, 2021

Correspondence

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Online download statistics by month:

Online download statistics by month: June 2020 to May 2023

	Abstract	Full	Pdf
Jun 2020	1220	1187	360
Jul 2020	339	340	72
Aug 2020	119	123	40
Sep 2020	128	123	46
Oct 2020	104	115	52
Nov 2020	88	88	47
Dec 2020	109	107	135
Jan 2021	122	122	157
Feb 2021	300	292	214
Mar 2021	169	159	144
Apr 2021	90	78	138
May 2021	80	65	117
Jun 2021	80	71	85
Jul 2021	71	67	82
Aug 2021	67	65	93
Sep 2021	78	78	106
Oct 2021	75	64	97
Nov 2021	33	26	101
Dec 2021	34	27	66
Jan 2022	60	51	91
Feb 2022	60	53	87
Mar 2022	48	43	75
Apr 2022	38	35	65
May 2022	45	44	64
Jun 2022	64	60	74
Jul 2022	43	37	38
Aug 2022	45	43	41
Sep 2022	50	44	74
Oct 2022	40	39	31
Nov 2022	36	31	27
Dec 2022	32	29	19
Jan 2023	52	48	38
Feb 2023	54	52	20
Mar 2023	45	41	52
Apr 2023	83	0	1
May 2023	46	2	1
Total	4147	3849	2950